A humanized antibody that binds to the interleukin 2 receptor - Test2 - elhamkhani - TriplyDB

A humanized antibody that binds to the interleukin 2 receptor

A humanized antibody that binds to the interleukin 2 receptor

http://www.wikidata.org/entity/Q24600912

about

Humanization of an anti-p185HER2 antibody for human cancer therapy Daclizumab therapy for multiple sclerosis Thermodynamic consequences of mutations in vernier zone residues of a humanized anti-human epidermal growth factor receptor murine antibody, 528 Critical contribution of VH-VL interaction to reshaping of an antibody: The case of humanization of anti-lysozyme antibody, HyHEL-10 Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis Reduced antibody response to streptavidin through site-directed mutagenesis Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody Outcome of a workshop on applications of protein models in biomedical research The Structural Basis of Antibody-Antigen Recognition The effects of interleukin-2 on immune response regulation.Humanized antibody neutralizing 2009 pandemic H1N1 virus.How long is a piece of loop?Use of a peptide mimotope to guide the humanization of MRK-16, an anti-P-glycoprotein monoclonal antibody.Phage display-selected sequences of the heavy-chain CDR3 loop of the anti-digoxin antibody 26-10 define a high affinity binding site for position 16-substituted analogs of digoxin.Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody.Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges.Next generation of antibody therapy for cancer.Specific binding of the pathogenic prion isoform: development and characterization of a humanized single-chain variable antibody fragment.Humanization and characterization of an anti-human TNF-α murine monoclonal antibody.Identification of human antibody fragment clones specific for tetanus toxoid in a bacteriophage lambda immunoexpression library.Advances in interleukin 2 receptor targeted treatment A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach.Vaccines and immunotherapeutics for the treatment of malignant disease Current treatment practice in immunosuppression.Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies.Arrayed protein library technology for therapeutic biologic discovery.Birth and future of multiscale modeling for macromolecular systems (Nobel Lecture).Developments in the treatment of uveitis.Frontier of therapeutic antibody discovery: The challenges and how to face them.Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing.Novel therapeutics for the treatment of graft-versus-host disease.Bench to bedside: new approaches to the immunotherapy of uveitic disease.The use of basiliximab in solid organ transplantation.Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.A fully caninised anti-NGF monoclonal antibody for pain relief in dogs A high-affinity CDR-grafted antibody against influenza A H5N1 viruses recognizes a conserved epitope of H5 hemagglutinin.

P2860

Q24561842-F8E356F6-0986-4D32-9B67-A1691CD57E1D Q27022517-2C4DDC2B-57D1-48ED-A922-06FF3A444AC0 Q27648835-20A1A32D-2261-40C1-8260-EE254A35284B Q27649729-1760E313-9D29-4629-8B96-267084B259D3 Q27684692-0AD038B5-9F20-425D-9D92-362C631F1A1C Q27693249-6240BD98-EA65-43FD-97EF-B7E01B76491C Q28364576-F27F1BF1-3F1C-4955-8899-8167D6388B5E Q28365417-B2FDDE2A-356F-4979-8309-9016432D92AF Q28731515-1A2991FD-8357-46D2-9DC9-C9B0F0C9CBC7 Q28751701-58120BEA-2CD9-488E-9643-867AB2DD37FD Q28972262-E94DB440-1161-4B88-AFF5-41C6D9390DD5 Q30252875-9AFA91D7-10FD-4066-8682-85AF52D44C7C Q30364911-7F39E8AC-B7C4-45A9-A2DA-77761645615F Q30430059-6B2C249C-8437-48E1-83E0-62302E2ED7EB Q30773361-9E398346-6A83-4D96-87FE-0FABDE3B491B Q30954494-5882592E-A336-46CD-9C3E-C7AEA45F790F Q31814859-BD40099C-1400-40BC-80D1-D4E0C1EFFF00 Q33224048-C932486E-F104-4CDE-AD50-346CA8F99E5C Q33579636-E8D773DA-0E59-4309-B4BD-28A39FD5A90E Q33809258-CCE469AE-A4F1-418F-B2DD-278D79CF2C8A Q33815758-8AF86165-E8F5-4C21-9FCF-3123D3DC7F3D Q33850314-7A14DA80-922F-4ACE-9488-241455F48B98 Q34071328-49A99BD8-F129-41C4-A620-21FAE4E530BA Q34104980-5F7552DA-2725-4FA9-B01F-4A5F4DC22F45 Q34170074-EBDAEE5E-3CC9-4195-B57A-0AC4E08E2165 Q34181796-5B15F01B-1582-4160-B817-86BEC04D8297 Q34223991-CC861A88-B9CE-43EC-A38C-663B7D3E023B Q34278192-878DF07E-5BC3-41B4-9F99-2BA8F3D9E71F Q34432654-7BC1FE4B-303C-4E6B-9354-37FFD7AA835D Q34481964-599F96C2-A334-4815-B7A8-EEC35E0A5107 Q34527769-0CE9B694-CA17-4F60-A432-3FCEFC909198 Q34596171-969BC933-3DA8-4C70-B9F3-565B7A341017 Q34762427-DAC3E353-DD3B-4C82-8534-125A0048B41A Q34772017-16AE23D3-D6F7-4435-A999-FE2A9AABB515 Q34841838-0124F5C4-BEE2-4362-BA22-56D20071E43D Q34993229-60BE423F-7E0E-4248-9FF3-F9832D51B238 Q35000988-8962B25A-AD35-4117-AE4F-1CBB94CBC2BB Q35012335-08AC37D0-F054-4980-98A4-67A7A5620D96 Q35037390-1B83C7E8-7D32-4466-96F0-E6F1560076CB Q35099676-AF7D9D25-B40D-4376-8E0C-A1C7F6C7449D

P2860

A humanized antibody that binds to the interleukin 2 receptor

http://www.wikidata.org/entity/Q24600912

description

1989 nî lūn-bûn

@nan

1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

A humanized antibody that binds to the interleukin 2 receptor

@ast

A humanized antibody that binds to the interleukin 2 receptor

@en

A humanized antibody that binds to the interleukin 2 receptor

@nl

type

label

A humanized antibody that binds to the interleukin 2 receptor

@ast

A humanized antibody that binds to the interleukin 2 receptor

@en

A humanized antibody that binds to the interleukin 2 receptor

@nl

prefLabel

A humanized antibody that binds to the interleukin 2 receptor

@ast

A humanized antibody that binds to the interleukin 2 receptor

@en

A humanized antibody that binds to the interleukin 2 receptor

@nl

P1433

Q24600912-D388C630-2922-435D-894F-F9A577369E06

P1476

Q24600912-28106798-41D1-4B57-8D7E-6CADEFB2EAC5

P2093

Q24600912-05750582-CF59-43F3-A67D-E4233F188295

Q24600912-26069F81-0E53-4B5C-A342-D9C2E616FC36

Q24600912-4F1F549A-03D4-47FC-A780-DCD0FB3D7123

Q24600912-8C44F84B-E85D-485E-88E9-31C432167076

Q24600912-C95FAE4E-DAC8-47DD-833B-F8102059485D

Q24600912-CDD8293B-722D-48EF-BBDB-F51E58FB34B9

Q24600912-D1EF6AC0-7D4B-43C0-A0CB-95A1B1AD940D

Q24600912-E62DC33B-E1A9-444C-A33C-EBE7835701AA

Q24600912-EBC12A7F-BEC5-412B-8E74-BD70614C9B1D

P2860

Q24600912-02798FEF-51A4-4D15-9D76-9F2DF41C9F5A

Q24600912-16D20523-AEFB-4F3A-9975-B785B8BC0493

Q24600912-20FB64F8-F57F-48E2-96EE-1A9B400582A8

Q24600912-2FE7BFAD-73BA-4571-9ECE-117BF2BB0EB8

Q24600912-3741E2BC-BDCF-4326-B717-FA5539F07D43

Q24600912-391B53F2-A52C-4C06-B552-3C43BA583F43

Q24600912-41C9379C-8872-4819-AD5F-2B539D1D07BE

Q24600912-4364D97B-F6A8-48C4-B1B4-EBF8D3C017E0

Q24600912-4B63DBFA-B8F7-46BD-A867-90F552E40C15

Q24600912-4CD1AB94-9E05-47B9-9384-5A14598E1700

P304

Q24600912-04F6D2CC-4229-4077-9694-8F750C0E2A06

P31

Q24600912-167A1E30-5C23-44AB-95DF-DE5B839A8D4B

P356

Q24600912-264BAAA8-783D-4F81-9566-F3F21BB2B2A3

P407

Q24600912-A7694952-7E25-4F90-9023-899AD135A2EE

P433

Q24600912-BB61B9DE-C5AC-4708-998B-2BF15CA656EE

P478

Q24600912-DDBA78C8-B38F-422A-98E0-F5EC627B46E1

P50

Q24600912-27E44E51-925F-4810-9B78-98C7ACEF968F

P577

Q24600912-5F2335AC-240A-468F-BDA4-BEA36920C777

P5875

Q24600912-C78F3BA2-F491-4F5A-99B9-882641F6FE46

P698

Q24600912-4C157C7B-44DE-4789-9A55-4FF1492F9CF6

P921

Q24600912-3937411A-D4C6-48F5-8508-F1676B99F65A

Q24600912-51198835-b6bf-419c-b8ff-df276a4c2467

P932

Q24600912-F7EE1BF2-69C0-4B8A-89A2-E48CA62438AD

P356

PNAS.86.24.10029

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A humanized antibody that binds to the interleukin 2 receptor

@en

P2093

C Queen

http://www.w3.org/2001/XMLSchema#string

H E Selick

http://www.w3.org/2001/XMLSchema#string

J F Duncan

http://www.w3.org/2001/XMLSchema#string

N F Landolfi

http://www.w3.org/2001/XMLSchema#string

N M Avdalovic

http://www.w3.org/2001/XMLSchema#string

P W Payne

http://www.w3.org/2001/XMLSchema#string

R P Junghans

http://www.w3.org/2001/XMLSchema#string

T A Waldmann

http://www.w3.org/2001/XMLSchema#string

W P Schneider

http://www.w3.org/2001/XMLSchema#string

P2860

DNA sequencing with chain-terminating inhibitors

The nucleotide sequence of a human immunoglobulin C gamma1 gene

Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors

A simple and very efficient method for generating cDNA libraries

Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments

Reshaping human antibodies for therapy

Replacing the complementarity-determining regions in a human antibody with those from a mouse

Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A.

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.

Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

P304

10029-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.86.24.10029

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

P577

1989-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20641712

http://www.w3.org/2001/XMLSchema#string

P698

2513570

http://www.w3.org/2001/XMLSchema#string

P921

P932

298637

http://www.w3.org/2001/XMLSchema#string